合計 50 件の最近のインサイダー取引記録が記録されています Incyte Corporation (INCY), 内訳は 16 件の買い および 33 件の売り. インサイダー買い総額は $8.39M インサイダー売り総額は $37.61M.
最近活動のある主要インサイダーには Harrigan Edmund, Baker Bros. Advisors Lp, Clancy Paul J. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — INCY
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-31 |
Harrigan Edmund |
Director |
RSU 付与（制限付株式） |
269 |
$94.12 |
$25.32K |
21,122 |
| 2026-03-31 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU 付与（制限付株式） |
421 |
- |
- |
2,818,039 |
| 2026-03-31 |
Clancy Paul J |
Director |
RSU 付与（制限付株式） |
265 |
$94.12 |
$24.94K |
23,741 |
| 2026-03-25 |
Trotta Matteo |
EVP, GM, Dermatology Us |
RSU 源泉徴収 |
537 |
$92.23 |
$49.53K |
14,882 |
| 2026-03-17 |
Cagnoni Pablo J |
President, R&d |
オプション行使（売却） |
7,166 |
$61.18 |
$438.42K |
9,102 |
| 2026-02-19 |
Cagnoni Pablo J |
President, R&d |
オプション行使（売却） |
13,093 |
$61.76 |
$808.62K |
7,182 |
| 2026-02-02 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU 源泉徴収 |
185 |
$102.67 |
$18.99K |
34,065 |
| 2026-02-02 |
Heeson Lee |
EVP, Head of Incyte Intl |
RSU 源泉徴収 |
111 |
$102.67 |
$11.4K |
38,041 |
| 2026-01-20 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU 源泉徴収 |
429 |
$102.62 |
$44.02K |
34,250 |
| 2026-01-16 |
Cagnoni Pablo J |
President, R&d |
RSU 付与（制限付株式） |
28,475 |
$106.21 |
$3.02M |
28,475 |
| 2026-01-16 |
Stein Steven H |
EVP & Chief Medical Officer |
RSU 付与（制限付株式） |
19,932 |
$106.21 |
$2.12M |
19,932 |
| 2026-01-16 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU 付与（制限付株式） |
7,426 |
- |
- |
34,679 |
| 2026-01-16 |
Tray Thomas |
Principal Accounting Officer |
RSU 付与（制限付株式） |
2,425 |
$106.21 |
$257.56K |
2,425 |
| 2026-01-16 |
Trotta Matteo |
EVP, GM, Dermatology Us |
RSU 付与（制限付株式） |
8,542 |
$106.21 |
$907.25K |
8,542 |
| 2026-01-16 |
Heeson Lee |
EVP, Head of Incyte Intl |
RSU 付与（制限付株式） |
8,911 |
- |
- |
38,152 |
| 2026-01-16 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
RSU 付与（制限付株式） |
14,237 |
$106.21 |
$1.51M |
14,237 |
| 2026-01-16 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
RSU 付与（制限付株式） |
4,218 |
$106.21 |
$447.99K |
4,218 |
| 2026-01-07 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
情報に基づく売り |
10,856 |
$109.07 |
$1.18M |
66,132 |
| 2026-01-06 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
RSU 源泉徴収 |
8,264 |
$106.66 |
$881.44K |
76,988 |
| 2026-01-05 |
Stein Steven H |
EVP & Chief Medical Officer |
情報に基づく売り |
15,634 |
$101.70 |
$1.59M |
34,203 |
| 2025-12-31 |
Harrigan Edmund |
Director |
RSU 付与（制限付株式） |
245 |
$98.77 |
$24.2K |
20,853 |
| 2025-12-31 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU 付与（制限付株式） |
328 |
- |
- |
2,817,618 |
| 2025-12-31 |
Clancy Paul J |
Director |
RSU 付与（制限付株式） |
241 |
$98.77 |
$23.8K |
23,476 |
| 2025-12-31 |
Stein Steven H |
EVP & Chief Medical Officer |
RSU 源泉徴収 |
13,292 |
$98.77 |
$1.31M |
49,837 |
| 2025-12-31 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU 源泉徴収 |
254 |
$98.77 |
$25.09K |
27,253 |
| 2025-12-19 |
Tray Thomas |
Principal Accounting Officer |
オプション行使（売却） |
1,044 |
$95.76 |
$99.97K |
- |
| 2025-12-18 |
Tray Thomas |
Principal Accounting Officer |
情報に基づく売り |
600 |
$98.25 |
$58.95K |
22,973 |
| 2025-12-17 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
情報に基づく売り |
4,323 |
$97.26 |
$420.45K |
27,507 |
| 2025-12-16 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
情報に基づく売り |
53,175 |
$97.29 |
$5.17M |
31,830 |
| 2025-12-11 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
情報に基づく売り |
255 |
$94.94 |
$24.21K |
60,011 |
| 2025-12-10 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
情報に基づく売り |
5,553 |
$95.58 |
$530.76K |
60,266 |
| 2025-12-08 |
Hoppenot Herve |
Director |
RSU 源泉徴収 |
2,843 |
$96.70 |
$274.92K |
326,803 |
| 2025-12-02 |
Stein Steven H |
EVP & Chief Medical Officer |
情報に基づく売り |
20,105 |
$102.51 |
$2.06M |
63,129 |
| 2025-12-01 |
Stein Steven H |
EVP & Chief Medical Officer |
RSU 源泉徴収 |
17,093 |
$102.04 |
$1.74M |
83,234 |
| 2025-12-01 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU 源泉徴収 |
326 |
$102.04 |
$33.27K |
85,838 |
| 2025-12-01 |
Hoffman Richard A. |
Officer |
不明 |
- |
- |
- |
- |
| 2025-12-01 |
Hoffman Richard A. |
EVP & General Counsel |
RSU 付与（制限付株式） |
9,466 |
- |
- |
9,466 |
| 2025-11-24 |
Tray Thomas |
Principal Accounting Officer |
情報に基づく売り |
600 |
$103.00 |
$61.8K |
23,573 |
| 2025-11-21 |
Tray Thomas |
Principal Accounting Officer |
情報に基づく売り |
169 |
$102.00 |
$17.24K |
24,173 |
| 2025-11-17 |
Denton Sheila A. |
EVP & General Counsel |
オプション行使（売却） |
278 |
$64.25 |
$17.86K |
8,883 |
| 2025-11-10 |
Hoppenot Herve |
Director |
情報に基づく売り |
187,500 |
$105.46 |
$19.77M |
329,646 |
| 2025-11-05 |
Stein Steven H |
EVP & Chief Medical Officer |
オプション行使（売却） |
1,194 |
$83.83 |
$100.09K |
- |
| 2025-11-04 |
Denton Sheila A. |
EVP & General Counsel |
オプション行使（売却） |
598 |
$58.06 |
$34.72K |
13,765 |
| 2025-11-03 |
Heeson Lee |
EVP, Head of Incyte Intl |
情報に基づく売り |
3,074 |
$94.02 |
$289.02K |
29,241 |
| 2025-10-15 |
Denton Sheila A. |
EVP & General Counsel |
オプション行使（売却） |
277 |
$64.25 |
$17.8K |
9,161 |
| 2025-10-03 |
Denton Sheila A. |
EVP & General Counsel |
情報に基づく売り |
3,501 |
$85.54 |
$299.48K |
26,569 |
| 2025-10-02 |
Denton Sheila A. |
EVP & General Counsel |
オプション行使（売却） |
599 |
$58.06 |
$34.78K |
14,363 |
| 2025-10-01 |
Heeson Lee |
EVP, Head of Incyte Intl |
RSU 源泉徴収 |
463 |
$86.70 |
$40.14K |
32,315 |
| 2025-10-01 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
RSU 源泉徴収 |
1,569 |
$86.70 |
$136.03K |
65,819 |
| 2025-09-30 |
Harrigan Edmund |
Director |
RSU 付与（制限付株式） |
289 |
$84.81 |
$24.51K |
20,608 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
